Fate Therapeutics (FATE) Current Deferred Revenue (2012 - 2026)
Fate Therapeutics' Current Deferred Revenue was $582,000 in Q1 2026, up 174.5% from $212,000 a year earlier and up 52.8% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Current Deferred Revenue (2012 - 2026) Analysis & Trends
At the end of FY2025, Current Deferred Revenue at Fate Therapeutics came in at $381,000, down 3.1% from FY2024.
- Current Deferred Revenue has now declined for three consecutive years, with a five-year compound annual growth rate of -55.2% (FY2020 to FY2025).
- In earlier years, Current Deferred Revenue was $393,000 in FY2024 (-42.6%), $685,000 in FY2023 (-98.4%), $42.23 million in FY2022 (+96.6%) and $21.48 million in FY2021 (+1.6%).
- The Q1 2026 figure marks the highest quarterly Current Deferred Revenue since Q3 2024.
- Compared with a year earlier, Current Deferred Revenue was higher in two of the last six quarters, with growth averaging 2.8%.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q1 2026 (growth of 174.5%); the worst was Q3 2025 (a decline of 99.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Fate Therapeutics | 252.23 Mn | 98.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 582,000.00 |
| Dec 31, 2025 | 381,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 212,000.00 |
| Dec 31, 2024 | 393,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 159,000.00 |
| Dec 31, 2023 | 685,000.00 |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 42.23 Mn |
| Sep 30, 2022 | 35.24 Mn |
| Jun 30, 2022 | 33.66 Mn |
| Mar 31, 2022 | 22.58 Mn |
| Dec 31, 2021 | 21.48 Mn |
| Sep 30, 2021 | 23.55 Mn |
| Jun 30, 2021 | 23.03 Mn |
| Mar 31, 2021 | 21.03 Mn |
| Dec 31, 2020 | 21.14 Mn |
API Access
Fate Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();